Mid Atlantic Financial Management’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$322K Sell
16,032
-4,913
-23% -$101K 0.02% 634
2021
Q2
$421K Buy
20,945
+8,595
+70% +$184K 0.03% 535
2021
Q1
$263K Sell
12,350
-305
-2% -$6.56K 0.02% 679
2020
Q4
$276K Sell
12,655
-1,992
-14% -$38.8K 0.02% 612
2020
Q3
$281K Buy
14,647
+158
+1% +$2.94K 0.02% 543
2020
Q2
$272K Sell
14,489
-19
-0.1% -$336 0.03% 516
2020
Q1
$251K Sell
14,508
-235
-2% -$4.91K 0.03% 498
2019
Q4
$311K Buy
14,743
+4,528
+44% +$91.7K 0.03% 518
2019
Q3
$200K Buy
+10,215
New +$188K 0.02% 621
2019
Q1
Sell
-10,658
Closed -$171K 749
2018
Q4
$171K Buy
+10,658
New +$169K 0.02% 611

Other funds holding MPT

Mid Atlantic Financial Management's MPT Position: Q3 2021 in Review

Mid Atlantic Financial Management reduced its Medical Properties Trust (MPT) stake by 23% in Q3 2021, selling an estimated $101K and leaving 16,032 shares worth $322K. The position accounts for 0.02% of the portfolio, ranked #634.

Mid Atlantic Financial Management first reported a position in MPT in Q4 2018 and has held it in 10 quarters since. The position peaked at $421K in Q2 2021. 564 funds tracked by Wall St. Rank hold MPT as of Q3 2021.

  • Mid Atlantic Financial Management held 16,032 shares of Medical Properties Trust worth $322K as of Q3 2021.
  • Mid Atlantic Financial Management sold 4,913 Medical Properties Trust shares in Q3 2021, an estimated $101K.
  • Medical Properties Trust made up 0.02% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #634 holding.
  • Mid Atlantic Financial Management first reported a position in Medical Properties Trust in Q4 2018 and has held it in 10 quarters since.
  • Mid Atlantic Financial Management's Medical Properties Trust position peaked at $421K in Q2 2021.
  • 564 funds tracked by Wall St. Rank held Medical Properties Trust as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.